1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,200 | 4,300 | 20:47 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Ovid Therapeutics, KemPharm leads healthcare gainers; Vir Biotechnology, NanoViricides among major losers | 15 | Seeking Alpha | ||
| Di | Mid-Day Market Update: Nasdaq Down 100 Points; NanoViricides Shares Spike Higher | 7 | Benzinga.com | ||
| NANOVIRICIDES Aktie jetzt für 0€ handeln | |||||
| Di | NanoViricides, CHF Solutions leads healthcare gainers; FibroGen, Neuronetics among major losers | 18 | Seeking Alpha | ||
| Di | NanoViricides Reports 'Strong Effectiveness' for COVID Drugs | 11 | The Street | ||
| Di | NNVC Stock: The COVID-19 Drug News That Has NanoViricides Rocketing Today | 10 | InvestorPlace | ||
| Di | The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data | 37 | Benzinga.com | ||
| Di | NanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studies | 16 | Seeking Alpha | ||
| Di | NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application | 493 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine... ► Artikel lesen | |
| 17.02. | NanoViricides reports FQ2 results | 8 | Seeking Alpha | ||
| 17.02. | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND | 1.553 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 16.02. | NANOVIRICIDES, INC. - 10-Q, Quaterly Report | 2 | SEC Filings | ||
| 08.02. | NanoViricides' Broad-Spectrum Antiviral Drug Candidate Shows Encouraging Action In Preclinical Studies For COVID-19 | 4 | Benzinga.com | ||
| 08.02. | NanoViricides's anti-coronavirus candidate was well tolerated in animal studies | 4 | Seeking Alpha | ||
| 08.02. | NanoViricides, Inc.: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies | 1.385 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based... ► Artikel lesen | |
| 27.01. | Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan | 908 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / January 27, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based... ► Artikel lesen | |
| 19.11.20 | NANOVIRICIDES, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 19.11.20 | NanoViricides, Inc.: NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA | 1.288 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, announced today that Mr. Brian... ► Artikel lesen | |
| 17.11.20 | NanoViricides reports FQ1 results | 9 | Seeking Alpha | ||
| 17.11.20 | NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress | 1.078 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / November 17, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen | |
| 11.11.20 | NanoViricides, Inc.: NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19 | 1.543 | ACCESSWIRE | SHELTON, CT / ACCESSWIRE / November 11, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 62,20 | +3,32 % | Formycon: US-Zulassungsantrag für FYB201 noch im ersten Halbjahr | Formycon meldet Neuigkeiten zum Lucentis Biosimilar-Kandidaten FYB201: Das Unternehmen und Lizenzpartner Bioeq AG planen nach Gesprächen mit der FDA weiterhin, für FYB201 im Laufe des ersten Halbjahres... ► Artikel lesen | |
| MAGFORCE | 4,600 | +0,88 % | Biotech Report: MagForce (MF6) und Vita34 (V3V) ziehen wieder an | (shareribs.com) Frankfurt 24.02.2021 - Biotech-Werte zeigen sich am Mittwoch überwiegend fester. Nach den massiven Kursverlusten der vergangenen Tage kommt es nun zu einer Gegenbewegung. Unter anderem... ► Artikel lesen | |
| NANOGATE | 0,972 | -5,17 % | Nanogate SE veräußert Nanogate Medical Systems | Die Geschäftsführung der Nanogate Medical Systems GmbH hat heute mit Zustimmung des Gläubigerausschusses der Muttergesellschaft Nanogate SE (ISIN: DE000A0JKHC9) die Veräußerung des Unternehmens an die... ► Artikel lesen | |
| KOPIN | 6,550 | -5,07 % | Kopin Jumps 21% In Premarket; Co. Reports Profit In Q4 | WASHINGTON (dpa-AFX) - Kopin Corporation (KOPN) reported net income for the fourth quarter of $1.3 million, or $0.02 per share, compared with net loss of $7.3 million, or $0.09 per share in... ► Artikel lesen | |
| STARPHARMA | 1,176 | -8,62 % | STARPHARMA HOLDINGS LIMITED: SPL7013 active against other pandemic coronaviruses | ||
| ONTO INNOVATION | 46,400 | -0,85 % | Onto Innovation Inc: Chip Tech Stock to Benefit from 5G Acceleration | Onto Innovation Inc Semiconductor Technology Could Be Huge in 5G
The race for 5G supremacy is well underway, especially given the restrictions on China's 5G technology sector. The shift in U.S. policy... ► Artikel lesen | |
| ITN NANOVATION | 0,268 | -2,19 % | PTA-AFR: ItN Nanovation AG: Korrektur zur Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: ItN Nanovation AG: Korrektur zur Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß §§ 114-117 WpHG
... ► Artikel lesen | |
| SIXTH WAVE INNOVATIONS | 0,270 | +8,87 % | Sixth Wave Innovations Inc.: Sixth Wave Imprints First Polymer for Detection of SARS-CoV-2 | Halifax, Nova Scotia--(Newsfile Corp. - February 9, 2021) - Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to announce a material... ► Artikel lesen | |
| VEECO INSTRUMENTS | 17,710 | +0,68 % | Veeco Instruments Inc.: Veeco Announces Capacity Expansion Plan for Laser Annealing Technology That Serves the World's Leading Semiconductor Customers | ||
| OBDUCAT | 0,085 | -22,73 % | Obducat receives order for an MC 204 fully automated resist processing tool from a customer in Asia | ||
| ACACIA RESEARCH | 5,400 | +1,89 % | Acacia Research: Next Generation Genomic Sequencing At A Bargain Price | ||
| NVE | 57,00 | +0,88 % | It Pays To Wait For NVE Corporation | ||
| LEHNER INVESTMENTS | 1,050 | 0,00 % | DGAP-Adhoc: LEHNER INVESTMENTS AG: Vorstand und Aufsichtsrat legen Ausgabebetrag und Volumen der Sachkapitalerhöhung fest | DGAP-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Kapitalmaßnahme
LEHNER INVESTMENTS AG: Vorstand und Aufsichtsrat legen Ausgabebetrag und Volumen der Sachkapitalerhöhung fest
14.12.2020 / 21:36... ► Artikel lesen | |
| NANOFOCUS | 1,040 | 0,00 % | Nanofocus: Späte Meldung der Umsetzung | Bei Nanofocus gibt es eine Kapitalherabsetzung. Eine außerordentliche Hauptversammlung hatte diesen Schritt am 5. November beschlossen. Am 5. Januar erfolgte die Eintragung ins Handelsregister. Heute... ► Artikel lesen | |
| RIBER | 1,515 | +1,34 % | Riber - FY20 revenues in line with management guidance | Riber has announced that FY20 revenues will total €30.2m, which is in line with its guidance of around €30m and our estimates. The year-end order book is around half the prior year level, reflecting... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
